{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T12:04:04Z","timestamp":1791633844779,"version":"4.3.4"},"reference-count":112,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.cll.2005.08.012","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T09:29:29Z","timestamp":1168421369000},"page":"809-825","source":"Crossref","is-referenced-by-count":41,"title":["Prognostic\/Predictive Factors in Breast Cancer"],"prefix":"10.1016","volume":"25","author":[{"given":"Shahla","family":"Masood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cll.2005.08.012_bib1","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJM198812293192601","article-title":"Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer: an overview of 61 randomized trials among 28,896 women","volume":"319","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cll.2005.08.012_bib2","first-page":"45","article-title":"Current status of Milan adjuvant chemotherapy trials for node-positive and node-negative breast ancer","volume":"1","author":"Bonadonna","year":"1986","journal-title":"NCI Monogr"},{"key":"10.1016\/j.cll.2005.08.012_bib3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1056\/NEJM198902233200802","article-title":"A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors","volume":"320","author":"Fisher","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cll.2005.08.012_bib4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1056\/NEJM198902233200801","article-title":"A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor negative tumors","volume":"320","author":"Fisher","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cll.2005.08.012_bib5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM198902233200803","article-title":"Efficiency of adjuvant chemotherapy in high-risk node negative breast cancer. An intergroup study","volume":"320","author":"Mansour","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cll.2005.08.012_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jama.1991.03460030097037","article-title":"Treatment of early stage breast cancer","volume":"265","author":"NIH Consensus Conference","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.cll.2005.08.012_bib7","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00000478-199104000-00002","article-title":"Prognosis and breast cancer\u2014recognition of lethal and favorable prognostic types","volume":"15","author":"Page","year":"1991","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cll.2005.08.012_bib8","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1200\/JCO.1989.7.10.1380","article-title":"Karnofsky memorial lecture. Conceptual and practical advances in the management of breast cancer","volume":"7","author":"Bonadonna","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cll.2005.08.012_bib9","first-page":"309","article-title":"The 182 National Survey of Carcinoma of the Breast in the United States by the American College of Surgeons","volume":"159","author":"Wilson","year":"1984","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.cll.2005.08.012_bib10","first-page":"528","article-title":"Ten year follow-up results of patients with carcinoma in the breast in a cooperative clinical trial evaluating surgical adjuvant chemotherapy","volume":"140","author":"Fisher","year":"1975","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.cll.2005.08.012_bib11","first-page":"839","article-title":"Axillary micrometastases and macrometastasis in carcinoma of the breast","volume":"144","author":"Atliyeh","year":"1977","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.cll.2005.08.012_bib12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/1097-0142(196902)23:2<243::AID-CNCR2820230201>3.0.CO;2-9","article-title":"The prognostic significance of palpable lymph nodes in cancer of the breast","volume":"23","author":"Cutler","year":"1969","journal-title":"Cancer"},{"key":"10.1016\/j.cll.2005.08.012_bib13","first-page":"1565","article-title":"International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancer","volume":"335","author":"Bettelheim","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.cll.2005.08.012_bib14","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/0140-6736(91)91768-P","article-title":"Axillary node micrometastasis and breast cancer","volume":"337","author":"Neville","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.cll.2005.08.012_bib15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/bjc.1987.59","article-title":"Micrometastasis to axillary lymph nodes from carcinoma of breast. Detection by immunohistochemistry and prognostic significance","volume":"55","author":"Trojani","year":"1987","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cll.2005.08.012_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/bjc.1984.162","article-title":"The immunocytochemical detection of axillary micrometastasis in breast cancer","volume":"50","author":"Wells","year":"1984","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cll.2005.08.012_bib17","series-title":"Cancer of the breast","first-page":"336","article-title":"Staging and primary treatment","author":"Donegan","year":"1988"},{"key":"10.1016\/j.cll.2005.08.012_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H","article-title":"Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases","volume":"63","author":"Carter","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.cll.2005.08.012_bib19","first-page":"527","article-title":"Prognostic factors in primary breast cancer","volume":"5","author":"McGuire","year":"1986","journal-title":"Cancer Surv"},{"key":"10.1016\/j.cll.2005.08.012_bib20","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/1097-0142(196911)24:5<1071::AID-CNCR2820240533>3.0.CO;2-H","article-title":"Cancer of the breast: size of neoplasm and prognosis","volume":"24","author":"Fisher","year":"1969","journal-title":"Cancer"},{"key":"10.1016\/j.cll.2005.08.012_bib21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/bjc.1984.112","article-title":"Breast cancer: relationship between the size of the primary tumor and the probability of metstatic dissemination","volume":"49","author":"Koscielny","year":"1984","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cll.2005.08.012_bib22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1200\/JCO.1989.7.3.355","article-title":"A long term follow-up study of survival in Stage I (T1N0M0) and Stage II (T1N0M0) breast carcinoma","volume":"7","author":"Rosen","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cll.2005.08.012_bib23","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1200\/JCO.1989.7.9.1239","article-title":"Pathological prognostic factors in Stage I (T1N0M0) and Stage II (T1N0M0) breast carcinoma: A study of 644 patients with median follow-up of 18 years","volume":"7","author":"Rosen","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cll.2005.08.012_bib24","first-page":"15","article-title":"Aspiration cytology of tubular breast carcinoma","volume":"34","author":"Bondensen","year":"1989","journal-title":"Acta Cytol"},{"key":"10.1016\/j.cll.2005.08.012_bib25","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0039-6109(16)45192-3","article-title":"Unusual lesions and their management","volume":"70","author":"Baker","year":"1990","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.cll.2005.08.012_bib26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2303.1990.tb00362.x","article-title":"Cytological grading of breast carcinoma: a feasible proposition?","volume":"1","author":"Hunt","year":"1990","journal-title":"Cytopathology"},{"key":"10.1016\/j.cll.2005.08.012_bib27","doi-asserted-by":"crossref","unstructured":"Howart AJ, Armstrong GR, Briggs WA, et al. Fine needle aspiration of palpable breast lumps: a 1-year audit using the cytospin method. Cytopathology 1992;3:17\u201322.","DOI":"10.1111\/j.1365-2303.1992.tb00016.x"},{"key":"10.1016\/j.cll.2005.08.012_bib28","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/0046-8177(93)90246-D","article-title":"Duct carcinoma of breast: nuclear grade as predictor of S-phase fraction","volume":"24","author":"Dabbs","year":"1993","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cll.2005.08.012_bib29","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0140-6736(94)90066-3","article-title":"Prognostic value of cytological grading of fine needle aspirates from breast carcinomas","volume":"343","author":"Robinson","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.cll.2005.08.012_bib30","first-page":"239","article-title":"Histologic grading of breast cancer","volume":"15","author":"Fisher","year":"1980","journal-title":"Pathol Annu"},{"issue":"3","key":"10.1016\/j.cll.2005.08.012_bib31","first-page":"263","article-title":"Prognostic value of nuclear grading in breast cytology","volume":"10","author":"Masood","year":"1994","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cll.2005.08.012_bib32","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/ajcp\/101.3.262","article-title":"Applicatoin of the Scarff-Bloom-Richardson tumor grading system to fine needle aspirates of the breast","volume":"101","author":"Howell","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cll.2005.08.012_bib33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/dc.2840100302","article-title":"Prognostic factors from the fine needle aspirate: breast carcinoma nuclear grade","volume":"10","author":"Dabbs","year":"1994","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.cll.2005.08.012_bib34","first-page":"14A","article-title":"Cytologic nuclear grading of fine needle aspirates of the breast carcinomas: concordance with histopathologic and flow data","volume":"2","author":"Cajulis","year":"1990","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cll.2005.08.012_bib35","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/jcp.39.5.489","article-title":"Value of cytoprognostic classification in breast carcinomas","volume":"39","author":"Moriguard","year":"1986","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.cll.2005.08.012_bib36","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/dc.2840030316","article-title":"The influence of the wet-fixed Papanicolaou and air-dried Giemsa techniques on nuclear parameters in breast cancer cytology: a cytomorphometric study","volume":"3","author":"Schulte","year":"1987","journal-title":"Diagn Cytopathol"},{"issue":"1","key":"10.1016\/j.cll.2005.08.012_bib37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/ajcp\/92.1.27","article-title":"Fine-needle aspiration cytology of metastatic neoplasms in the breast","volume":"92","author":"Sneige","year":"1989","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cll.2005.08.012_bib38","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/dc.2840090210","article-title":"Prognostic value of breast cancer cytologic grading: a retrospective study of 213 cases","volume":"9","author":"Ciatto","year":"1993","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.cll.2005.08.012_bib39","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1056\/NEJM199208063270606","article-title":"Breast cancer","volume":"327","author":"Harris","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cll.2005.08.012_bib40","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/1097-0142(19881215)62:12<2507::AID-CNCR2820621210>3.0.CO;2-D","article-title":"Management of Stage II primary cancer with primary chemotherapy, surgery and radiation therapy","volume":"62","author":"Hortobagyi","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.cll.2005.08.012_bib41","first-page":"104","article-title":"On treatment of inoperable cases of carcinoma of the mamma. Suggestions for new method of treatment with illustrated cases","volume":"2","author":"Beatson","year":"1986","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cll.2005.08.012_bib42","first-page":"9","article-title":"Studies on prostatic cancer. The effect of castration of estrogen and androgen injection on serum phosphatase in metastatic carcinoma of the prostate","volume":"168","author":"Huggins","year":"1941","journal-title":"Cancer Res"},{"key":"10.1016\/j.cll.2005.08.012_bib43","first-page":"134","article-title":"Inhibition of human mammary and prostatic cancers by adrenalectomy","volume":"12","author":"Huggins","year":"1952","journal-title":"Cancer Res"},{"key":"10.1016\/j.cll.2005.08.012_bib44","series-title":"Endocrine aspects of breast cancer. Proceedings of conference held at University of Glasgow","first-page":"27","article-title":"Hyphophysectomy in management of metastatic carcinoma of breast","author":"Luft","year":"1958"},{"key":"10.1016\/j.cll.2005.08.012_bib45","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/1097-0142(196901)23:1<145::AID-CNCR2820230119>3.0.CO;2-P","article-title":"Bilateral adrenalectomy in metastatic mammary cancer: an analysis of sixty-four cases","volume":"23","author":"Harris","year":"1969","journal-title":"Cancer"},{"key":"10.1016\/j.cll.2005.08.012_bib46","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0140-6736(61)91088-1","article-title":"Studies with tritium labelled hexestrol in advanced breast cancer","volume":"2","author":"Folca","year":"1961","journal-title":"Lancet"},{"key":"10.1016\/j.cll.2005.08.012_bib47","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1073\/pnas.55.6.1574","article-title":"A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterization","volume":"55","author":"Toft","year":"1966","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cll.2005.08.012_bib48","series-title":"Some aspects of aetiology and biochemistry of prostatic cancer","article-title":"Pattern of hormone receptor interactions","author":"Jensen","year":"1970"},{"key":"10.1016\/j.cll.2005.08.012_bib49","first-page":"337","article-title":"Estrogen receptors in human breast cancer tissue","volume":"113","author":"Mass","year":"1972","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cll.2005.08.012_bib50","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/bmj.2.5869.750","article-title":"Oestrogen receptors in human breast cancer tissue and response to endocrine therapy","volume":"2","author":"Engelsman","year":"1973","journal-title":"BMJ"},{"key":"10.1016\/j.cll.2005.08.012_bib51","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1001\/archsurg.1973.01350160129021","article-title":"Predictability of response to endocrine ablation in advanced breast carcinoma","volume":"106","author":"Leung","year":"1973","journal-title":"Arch Surg"},{"key":"10.1016\/j.cll.2005.08.012_bib52","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/1097-0142(197402)33:2<303::AID-CNCR2820330202>3.0.CO;2-7","article-title":"Correlation between certain biochemical properties of breast cancer and response to therapy. Preliminary report","volume":"33","author":"Savlov","year":"1974","journal-title":"Cancer"},{"key":"10.1016\/j.cll.2005.08.012_bib53","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1126\/science.168640","article-title":"Predicting a response to endocrine therapy in human breast cancer. A hypothesis","volume":"189","author":"Harwitz","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.cll.2005.08.012_bib54","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM198312013092240","article-title":"Progesterone receptors as a prognostic factor in Stage II breast cancer","volume":"309","author":"Clark","year":"1983","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.cll.2005.08.012_bib55","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/dc.2840080508","article-title":"Estrogen and progesterone receptors in cytology","volume":"8","author":"Masood","year":"1992","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.cll.2005.08.012_bib56","first-page":"6,724","article-title":"Potential value of estrogen receptor immunocyto-chemical assay in formalin fixed breast tumors","volume":"3","author":"Masood","year":"1990","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cll.2005.08.012_bib57","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/1097-0142(19801215)46:12+<2884::AID-CNCR2820461429>3.0.CO;2-U","article-title":"The value of estrogen and progesterone receptors in the treatment of breast cancer","volume":"46","author":"Osborne","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.cll.2005.08.012_bib58","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF01807890","article-title":"Correlation of primary breast cancer histopathology and estrogen receptor content","volume":"1","author":"Fisher","year":"1981","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cll.2005.08.012_bib59","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/1097-0142(19880201)61:3<420::AID-CNCR2820610303>3.0.CO;2-0","article-title":"DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens","volume":"61","author":"Dressler","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.cll.2005.08.012_bib60","series-title":"Breast diseases","first-page":"210","article-title":"Receptors","author":"Osborne","year":"1987"},{"key":"10.1016\/j.cll.2005.08.012_bib61","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0046-8177(90)90026-2","article-title":"Mitosis counting in tumors","volume":"21","author":"Baak","year":"1990","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cll.2005.08.012_bib62","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0046-8177(91)90080-9","article-title":"The morphometric prognostic index is the strongest prognosticator in premenopausal lymph node negative and lymph node positive breast cancer patients","volume":"22","author":"Van viest","year":"1990","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cll.2005.08.012_bib63","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1097-0142(19910915)68:6<1309::AID-CNCR2820680621>3.0.CO;2-I","article-title":"Pathologic correlates of survival in 378 lymph node negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictor","volume":"68","author":"Clayton","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.cll.2005.08.012_bib64","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/1097-0142(19830515)51:10<1879::AID-CNCR2820511021>3.0.CO;2-9","article-title":"Predicition of early course of breast carcinoma by thymidine labelling","volume":"51","author":"Meyer","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.cll.2005.08.012_bib65","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/ijc.2910330404","article-title":"The long term prognostic significance of the thymidine labeling index in breast cancer","volume":"33","author":"Tubiana","year":"1984","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cll.2005.08.012_bib66","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF01806389","article-title":"Practical breast carcinoma cell kinetics: review and update","volume":"4","author":"Meyer","year":"1984","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.cll.2005.08.012_bib67","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/bjc.1987.258","article-title":"Tumour DNA ploidy as an independent prognostic factor in breast cancer","volume":"56","author":"Kallioniemi","year":"1987","journal-title":"Br J Cancer"},{"issue":"10","key":"10.1016\/j.cll.2005.08.012_bib68","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/1097-0142(19881115)62:10<2183::AID-CNCR2820621019>3.0.CO;2-B","article-title":"Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction. A proposed classification of DNA histograms in breast cancer","volume":"62","author":"Kallinoiemi","year":"1988","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.cll.2005.08.012_bib69","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1056\/NEJM198903093201003","article-title":"Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry","volume":"320","author":"Clark","year":"1989","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.cll.2005.08.012_bib70","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1002\/1097-0142(19900515)65:10<2315::AID-CNCR2820651025>3.0.CO;2-3","article-title":"Prognostic significance of flow cytometric DNA analysis in node-negative breast cancer patients","volume":"65","author":"Lewis","year":"1990","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.cll.2005.08.012_bib71","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/1097-0142(19900401)65:7<1577::AID-CNCR2820650721>3.0.CO;2-D","article-title":"Is DNA ploidy an independent prognostic indicator in infiltrative node-negative breast adenocarcinoma?","volume":"65","author":"Keyhani-Rofagha","year":"1990","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.cll.2005.08.012_bib72","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/bjc.1989.342","article-title":"The prognostic significance of nuclear DNA in invasive breast cancer\u2014a study with long-term follow-up","volume":"60","author":"Toikkanen","year":"1989","journal-title":"Br J Cancer"},{"issue":"15","key":"10.1016\/j.cll.2005.08.012_bib73","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJM199004123221505","article-title":"Indicators of prognosis in node-negative breast cancer","volume":"322","author":"Sigurdsson","year":"1990","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.cll.2005.08.012_bib74","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/1097-0142(19911001)68:7<1465::AID-CNCR2820680702>3.0.CO;2-I","article-title":"DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04","volume":"68","author":"Fisher","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.cll.2005.08.012_bib75","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/archsurg.1992.01420120020003","article-title":"Prognostic factors in node-negative breast cancer","volume":"127","author":"Johnson","year":"1992","journal-title":"Arch Surg"},{"key":"10.1016\/j.cll.2005.08.012_bib76","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/cyto.990140505","article-title":"Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast","volume":"14","author":"Hedley","year":"1993","journal-title":"Cytometry"},{"issue":"17","key":"10.1016\/j.cll.2005.08.012_bib77","first-page":"4729","article-title":"Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer","volume":"47","author":"Hedley","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.cll.2005.08.012_bib78","doi-asserted-by":"crossref","unstructured":"Stal O, Sullivan S, Wingren S, Carstensen J, et al. C-erbB-2 expression and benefit from adjuvant chemotherapy and radiotherapy of breast cancer. Eur J Cancer 1995;31A(13\u201314):2185\u201390.","DOI":"10.1016\/0959-8049(95)00344-4"},{"issue":"9","key":"10.1016\/j.cll.2005.08.012_bib79","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/1097-0142(19891101)64:9<1894::AID-CNCR2820640923>3.0.CO;2-K","article-title":"The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer","volume":"64","author":"Muss","year":"1989","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.cll.2005.08.012_bib80","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/bjc.1990.380","article-title":"Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels","volume":"62","author":"Sigurdsson","year":"1990","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.cll.2005.08.012_bib81","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/bjc.1990.152","article-title":"DNA index, S-phase fraction, histological grade and prognosis in breast cancer","volume":"61","author":"O'Reilly","year":"1990","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.cll.2005.08.012_bib82","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/1097-0142(19880801)62:3<521::AID-CNCR2820620314>3.0.CO;2-F","article-title":"Predictive value of nuclear DNA content in breast cancer in relation to clinical and morphological factors. A retrospective study of 227 consecutive cases","volume":"62","author":"Falleninis","year":"1988","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.cll.2005.08.012_bib83","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/cyto.990120209","article-title":"Response to Beerman et al, \u201cFlow cytometric analysis of DNA stemline heterogeneity in primary and metastatic breast cancer.\u201d","volume":"12","author":"Kute","year":"1991","journal-title":"Cytometry"},{"key":"10.1016\/j.cll.2005.08.012_bib84","series-title":"Guides to clinical aspiration biopsy: flow cytometry","author":"Vielh","year":"1991"},{"key":"10.1016\/j.cll.2005.08.012_bib85","article-title":"Use of fine needle aspiration biopsy specimens in DNA flow cytometry study","volume":"92","author":"Masood","year":"1989","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cll.2005.08.012_bib86","first-page":"731","article-title":"Modalities of synthesis of Ki-67 antigen during the stimulation of lymphocytes","volume":"10","author":"Lopez","year":"1989","journal-title":"Cytometry"},{"key":"10.1016\/j.cll.2005.08.012_bib87","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/cyto.990130304","article-title":"Flow cytometric analysis of proliferation associated nuclear antigen using washless staining of unfixed cells","volume":"13","author":"Landberg","year":"1992","journal-title":"Cytometry"},{"key":"10.1016\/j.cll.2005.08.012_bib88","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/dc.2840090111","article-title":"Detection of growth fraction in tumors by Ki-67 monoclonal antibody in cytologic smears: a prospective study of 40 cases","volume":"9","author":"Rishi","year":"1993","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.cll.2005.08.012_bib89","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/dc.2840070608","article-title":"Cytologic assessment of tumor cell kinetics. Applications of monoclonal antibody Ki-67 to fine needle aspiration smears","volume":"7","author":"Henry","year":"1991","journal-title":"Diagn Cytopathol"},{"issue":"6","key":"10.1016\/j.cll.2005.08.012_bib90","first-page":"S84","article-title":"Prognostic factors in breast cancer, use of fine needle aspirates","volume":"36","author":"Masood","year":"1992","journal-title":"Acta Cytol"},{"key":"10.1016\/j.cll.2005.08.012_bib91","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1200\/JCO.1987.5.7.999","article-title":"Proto-oncogene abnormalities in human breast cancer: correlations with anatomic features and clinical course of disease","volume":"5","author":"Cline","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cll.2005.08.012_bib92","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.cll.2005.08.012_bib93","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1200\/JCO.1989.7.8.1120","article-title":"HER-2\/neu oncogene protein and prognosis in breast cancer","volume":"7","author":"Tandon","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cll.2005.08.012_bib94","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1200\/JCO.1990.8.1.103","article-title":"Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic signficance of erbB-2 protein overexpression in primary breast cancer","volume":"8","author":"Paik","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cll.2005.08.012_bib95","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1200\/JCO.1992.10.4.599","article-title":"HER-2\/neu in node negative breast cancer. Prognostic significance of overexpression influenced by presence of in situ carcinoma","volume":"10","author":"Allred","year":"1992","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.cll.2005.08.012_bib96","first-page":"12A","article-title":"HER-2\/neu oncogene expression in atypical hyperplasia, carcinoma in situ and invasive breast cancer","volume":"4","author":"Masood","year":"1991","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cll.2005.08.012_bib97","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/1097-0339(200011)23:5<299::AID-DC2>3.0.CO;2-X","article-title":"HER-2\/neu gene amplification in breast imprint cytology analyzed by fluorescence in situ hybridization: direct comparison with companion tissue sections","volume":"23","author":"Moore","year":"2000","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.cll.2005.08.012_bib98","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1309\/0F58-0GRX-FK4R-A6VA","article-title":"Sensitivity of HER-2\/neu antibodies in archival tissue samples of invasive breast carcinomoas. Correlation with oncogene amplification in 160 cases","volume":"113","author":"Gancberg","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cll.2005.08.012_bib99","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.bjc.6690387","article-title":"erbB2\/neu gene and chromosome 17 analysis in breast cancer by FISH on archival cytological fine-needle aspirates","volume":"80","author":"Mezzelani","year":"1999","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.cll.2005.08.012_bib100","first-page":"259","article-title":"Assessment of HER-2\/neu overexpression in primary breast cancers and their metastatic lesions: an immunohistochemical study","volume":"30","author":"Masood","year":"2000","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.cll.2005.08.012_bib101","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/mp.52.2.75","article-title":"Fluorescence in situ hybridization detection of erbB2 amplification in breast cancer fine needle aspirates","volume":"52","author":"McManus","year":"1999","journal-title":"Mol Pathol"},{"key":"10.1016\/j.cll.2005.08.012_bib102","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0092-8674(89)90045-7","article-title":"The p53 proto-oncogenes can act as a suppressor of transformation","volume":"57","author":"Finlay","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.cll.2005.08.012_bib103","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0092-8674(91)90636-D","article-title":"Molecular themes in oncogenes","volume":"64","author":"Bishop","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.cll.2005.08.012_bib104","first-page":"6194","article-title":"Mutations in p53 gene in primary human breast cancers","volume":"51","author":"Osborne","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.cll.2005.08.012_bib105","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/jnci\/84.11.845","article-title":"Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancer","volume":"84","author":"Thor","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cll.2005.08.012_bib106","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/jnci\/84.14.1109","article-title":"Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients","volume":"84","author":"Isola","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cll.2005.08.012_bib107","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/jnci\/84.11.845","article-title":"Increased accumulation of the p53 suppressor gene product is an independent prognostic variable for breast cancer","volume":"84","author":"Thor","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cll.2005.08.012_bib108","unstructured":"Addonizio LJ, Robbins RC. Pulmonary vascular resistance. In: Smith JK, editor. Proceedings of the Fourth International Symposium on Circulation. Las Vegas (NV): Real Science Press; 1987. p. 12\u2013189."},{"issue":"1","key":"10.1016\/j.cll.2005.08.012_bib109","article-title":"p53 oncosuppressor protein in carcinoma of the breast","volume":"6","author":"Masood","year":"1991","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cll.2005.08.012_bib110","first-page":"259","article-title":"Relation between p53 overexpression and established prognostic factors in breast cancer","volume":"110","author":"Davidoff","year":"1991","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.cll.2005.08.012_bib111","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/bjc.1994.225","article-title":"p53 mutations and overexpression in locally advanced breast cancer","volume":"69","author":"Faille","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cll.2005.08.012_bib112","first-page":"2605","article-title":"Maintenance of p53 alterations throughout breast cancer progression","volume":"51","author":"David","year":"1991","journal-title":"Cancer Res"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271205000831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271205000831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T12:52:32Z","timestamp":1556023952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271205000831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":112,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0272271205000831"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2005.08.012","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}